- Home
- CZWI vs MIST Comparison
CZWI vs MIST Comparison
Compare CZWI & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CZWI | MIST |
|---|---|---|
| Founded | 1938 | 2003 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 194.1M | 176.3M |
| IPO Year | 2006 | 2019 |
Fundamental Metrics
Financial Performance| Metric | CZWI | MIST |
|---|---|---|
| Price | $20.51 | $2.02 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | 45.4K | ★ 3.0M |
| Earning Date | 04-27-2026 | 05-13-2026 |
| Dividend Yield | ★ 2.05% | N/A |
| EPS Growth | ★ 8.96 | N/A |
| EPS | ★ 1.46 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $13.02 | $2,915.14 |
| Revenue Next Year | $9.42 | N/A |
| P/E Ratio | $14.06 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.15 | $0.77 |
| 52 Week High | $20.94 | $3.06 |
Technical Indicators
Market Signals| Indicator | CZWI | MIST |
|---|---|---|
| Relative Strength Index (RSI) | 70.82 | 67.19 |
| Support Level | $17.38 | $1.89 |
| Resistance Level | N/A | $2.28 |
| Average True Range (ATR) | 0.34 | 0.16 |
| MACD | 0.06 | 0.10 |
| Stochastic Oscillator | 82.84 | 86.32 |
Price Performance
Historical ComparisonAbout CZWI Citizens Community Bancorp Inc.
Citizens Community Bancorp Inc is a bank holding company that offers traditional community banking services to businesses, Agricultural operators, and consumers, including one-to-four-family residential mortgages. it also offers a variety of loan products including commercial real estate loans, commercial and industrial (C&I) loans, agricultural real estate loans, agricultural operating loans, residential mortgages, home equity lines-of-credit, and consumer loans and offers deposit products through its branches, including demand deposits, various savings and money-market accounts and certificates of deposit. The company's sources of funds are deposits; amortization, prepayments, and maturities of outstanding loans; other short - term investments; and funds provided from operations.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).